(Q57758019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

patient

0 references

hepatocellular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Roberto Labianca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Camillo Porta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Guido Torzilli

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Laura Giordano

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Armando Santoro

1 reference

ORCID Public Data File 2021

author name string

T Pressiani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Boni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Fagiuoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Salvagni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

D Ferrari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

E Cortesi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Mucciarini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Latini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Carnaghi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M Banzi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Fanello

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M De Giorgio

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

F R Lutman

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M A Tommasini

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

R Ceriani

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

G Covini

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M C Tronconi

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

N Locopo

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Naimo

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Santoro

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

5 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

406-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib: a review of its use in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib: in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS343

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041587%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference